Solid State Characterization and Pharmaceutical Development | OMICS International| Abstract
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Short Communication   
  • J Anal Bioanal Tech,
  • DOI: 10.4172/2155-9872.1000433

Solid State Characterization and Pharmaceutical Development

Kaushalendra Chaturvedi*
Research Department, J-Star Research Inc, United States
*Corresponding Author : Kaushalendra Chaturvedi, Research Department, J-Star Research Inc, United States, Email: [email protected]


Pharmaceutical materials solid-state property plays a critical role from early discovery to finalizing the formulation type. Pharmaceutical material exists in a crystalline or amorphous state. The crystalline state generally shows a high melting point, less hygroscopic, low solubility, lower bioavailability, and higher Physico-chemical stability compared to the amorphous material. A major concern in the pharmaceutical industry is the selection of solids state forms for the final formulations. This is because it can significantly affect the drug product quality in terms of Physicochemical
stability, processibility, solubility, bioavailability, and having regulatory, legal, and commercial implications.

Keywords:  Pharmaceutical materials; Crystalline; Hygroscopic